HUE026600T2 - Készítmények és eljárások virális hepatitis kezelésére - Google Patents
Készítmények és eljárások virális hepatitis kezeléséreInfo
- Publication number
- HUE026600T2 HUE026600T2 HUE07849216A HUE07849216A HUE026600T2 HU E026600 T2 HUE026600 T2 HU E026600T2 HU E07849216 A HUE07849216 A HU E07849216A HU E07849216 A HUE07849216 A HU E07849216A HU E026600 T2 HUE026600 T2 HU E026600T2
- Authority
- HU
- Hungary
- Prior art keywords
- compositions
- treatment
- methods
- viral hepatitis
- hepatitis
- Prior art date
Links
- 206010019799 Hepatitis viral Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 201000001862 viral hepatitis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10041—Use of virus, viral particle or viral elements as a vector
- C12N2720/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10061—Methods of inactivation or attenuation
- C12N2720/10062—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10061—Methods of inactivation or attenuation
- C12N2720/10064—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP0600894 | 2006-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE026600T2 true HUE026600T2 (hu) | 2016-06-28 |
Family
ID=89620371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE07849216A HUE026600T2 (hu) | 2006-12-01 | 2007-11-22 | Készítmények és eljárások virális hepatitis kezelésére |
Country Status (4)
Country | Link |
---|---|
US (1) | US8398969B2 (hu) |
EP (1) | EP2101797B1 (hu) |
HU (1) | HUE026600T2 (hu) |
WO (1) | WO2008068661A1 (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2407534A1 (en) * | 2010-07-14 | 2012-01-18 | Neo Virnatech, S.L. | Methods and reagents for obtaining transcriptionally active virus-like particles and recombinant virions |
US20210386804A1 (en) * | 2020-06-11 | 2021-12-16 | Tibor Bakács | Combination of viral superinfection therapy with subthreshold doses of nivolumab plus ipilimumab in chronic HBV patients |
US20240024390A1 (en) * | 2020-12-21 | 2024-01-25 | Probiogen Ag | Use of a birnavirus alone or in combimation therapy for the treatment of a disease caused by a nidovirus |
US20240299476A1 (en) * | 2020-12-21 | 2024-09-12 | Probiogen Ag | Use of a birnavirus alone or in combination therapy for the treatment of cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU197846B (en) * | 1984-07-02 | 1989-06-28 | Laszlo Csatary | Process for producing therapeutic composition suitable for treating virus infections |
US5215745A (en) | 1988-04-27 | 1993-06-01 | United Cancer Research Institute | Method for treating viral diseases with attenuated virus |
US5124148A (en) | 1988-04-27 | 1992-06-23 | United Cancer Research Institute | Method for treating viral diseases with attenuated virus |
US5602023A (en) | 1992-03-24 | 1997-02-11 | Csatary; Laszlo K. | Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same |
CA2192442C (en) | 1994-06-10 | 2007-09-25 | Imre Kovesdi | Complementary adenoviral vector systems and cell lines |
US5871744A (en) | 1996-09-05 | 1999-02-16 | University Of Maryland-Biotechnology Inst. | Method for generating birnavirus from synthetic RNA transcripts |
CA2238659C (en) * | 1997-05-26 | 2010-12-14 | Akzo Nobel N.V. | Recombinant birnavirus vaccine |
US6596280B1 (en) | 1997-07-31 | 2003-07-22 | University Of Maryland Biotechnology Institute | Method for generating birnavirus from synthetic RNA transcripts |
US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
EP1069187A1 (en) * | 1999-07-14 | 2001-01-17 | Stichting Dienst Landbouwkundig Onderzoek | Mosaic Infectious Bursal Disease Virus vaccines |
-
2007
- 2007-11-22 WO PCT/IB2007/054742 patent/WO2008068661A1/en active Application Filing
- 2007-11-22 EP EP07849216.2A patent/EP2101797B1/en not_active Not-in-force
- 2007-11-22 HU HUE07849216A patent/HUE026600T2/hu unknown
-
2009
- 2009-05-29 US US12/475,127 patent/US8398969B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8398969B2 (en) | 2013-03-19 |
EP2101797B1 (en) | 2015-08-26 |
US20090291063A1 (en) | 2009-11-26 |
WO2008068661A1 (en) | 2008-06-12 |
EP2101797A1 (en) | 2009-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL197804A0 (en) | Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c | |
AP2907A (en) | Viral hepatitis treatment | |
HRP20160410T8 (hr) | Inhibitori hepatitis c virusa | |
EP2331123A4 (en) | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C | |
IL198248A0 (en) | Hepatitis c virus inhibitors and compositions comprising the same | |
IL195272A0 (en) | Methods and compositions for the treatment of viral infections | |
HK1134679A1 (zh) | 用於治療感染的組合物和方法 | |
IL198087A0 (en) | Methods of inactivating viruses | |
EP2361089A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE | |
IL197148A0 (en) | Methods and compositions for the treatment of antibody mediated neuropathies | |
ZA200803493B (en) | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection | |
HK1223968A1 (zh) | 狂犬病病毒組合物和方法 | |
AP2009004840A0 (en) | Compounds and methods for treatment of HCV | |
IL196843A0 (en) | Compositions and methods for the treatment of radiation proctosigmoitis | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
EP2049151A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
EP2007381A4 (en) | COMPOSITIONS AND METHODS OF USING RITONAVIR FOR THE TREATMENT OF HEPATITIS C VIRUS | |
EP1901752A4 (en) | COMPOSITIONS AND METHODS FOR VIRAL INHIBITION | |
HUE026600T2 (hu) | Készítmények és eljárások virális hepatitis kezelésére | |
EP2196211A4 (en) | APOLACTOFERRIN COMPOSITIONS AND METHOD FOR THEIR USE IN THE TREATMENT OF VIRAL HEPATITIS C | |
ZA201103090B (en) | Herbal composition and method for the treatment of viral infection | |
ZA200902434B (en) | Compounds and methods for treatment of HCV | |
GB0617310D0 (en) | Treatment of hepatitis c | |
GB0717139D0 (en) | Treatment of hepatitis C | |
HUS1500008I1 (hu) | Hepatitis C vírus inhibitorok |